Home > Healthcare > Medical Devices > Surgical Devices > Pediatric Perfusion Systems Market

Pediatric Perfusion Systems Market Share

Report ID: GMI7499
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Pediatric Perfusion Systems Market Share

The pediatric perfusion systems industry is fragmented in nature, with a large number of small and medium-sized companies, along with major industry players competing with each other. However, key market players are focusing on improving their market share including Medtronic, LivaNova PLC, Terumo Cardiovascular Systems Corporation, among others. The market players are focusing on strategies including innovating and developing new products and services.

Some of the eminent market participants operating in the pediatric perfusion systems industry include:

Medtronic
LivaNova PLC
Terumo Cardiovascular Systems Corporation
BL Lifesciences
Cardinal Health
EUROSETS
Getinge AB
Nonin
Edwards Lifesciences Corporation
Stryker Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The pediatric perfusion systems industry was valued at USD 318.9 million in 2022 and is estimated to reach over USD 627 million by 2032, attributed to the growing demand for minimally invasive procedures in pediatric cardiac surgery, favorable government initiatives and reimbursement policies.

The pediatric oxygenators segment garnered around USD 99.1 million revenue in 2022. Due to congenital heart defects, neonates and newborns often require cardiac surgeries or procedures, pushing the demand for the specialised oxygenation to meet the physiological requirements of the youngest patients.

North America pediatric perfusion system market accounted for USD 131.6 million in 2022 and is predicted to witness substantial growth as there is a growing focus on pediatric cardiac care in the region, leading to increased investments in specialized services and technologies.

Medtronic, LivaNova PLC, Terumo Cardiovascular Systems Corporation, BL Lifesciences, Cardinal Health, EUROSETS, Getinge AB, Nonin, Edwards Lifesciences Corporation, and Stryker Corporation.